|
MTFMT expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.33390000051281E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.44089999998265E-06 |
| Normal-vs-Stage2 |
3.246000E-02 |
| Normal-vs-Stage3 |
5.502000E-02 |
| Normal-vs-Stage4 |
6.952300E-02 |
| Stage1-vs-Stage2 |
9.092200E-01 |
| Stage1-vs-Stage3 |
7.010000E-01 |
| Stage1-vs-Stage4 |
8.411600E-01 |
| Stage2-vs-Stage3 |
8.693200E-01 |
| Stage2-vs-Stage4 |
9.223400E-01 |
| Stage3-vs-Stage4 |
9.611000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.55199999962718E-07 |
| Normal-vs-AfricanAmerican |
1.909530E-02 |
| Normal-vs-Asian |
6.162000E-01 |
| Caucasian-vs-AfricanAmerican |
1.393580E-01 |
| Caucasian-vs-Asian |
3.734400E-01 |
| AfricanAmerican-vs-Asian |
7.111600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.95990004412539E-09 |
| Normal-vs-Female |
1.045230E-01 |
| Male-vs-Female |
2.816700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.144610E-03 |
| Normal-vs-Extreme_Weight |
5.20369999978954E-07 |
| Normal-vs-Obese |
8.606600E-04 |
| Normal-vs-Extreme_Obese |
4.690400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.850200E-01 |
| Normal_Weight-vs-Obese |
8.621200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.017800E-01 |
| Extreme_Weight-vs-Obese |
5.167800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.239800E-01 |
| Obese-vs-Extreme_Obese |
4.704800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.539760E-03 |
| Normal-vs-Age(41-60Yrs) |
1.365880E-04 |
| Normal-vs-Age(61-80Yrs) |
1.61687999999938E-05 |
| Normal-vs-Age(81-100Yrs) |
2.481100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.866600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.640800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.556300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.480600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.661700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.320300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.28549999995387E-07 |
| Normal-VS-Type2 PRCC |
1.879820E-03 |
| Normal-VS-KIRP CIMP |
4.578900E-03 |
| Normal-VS-Unclassified PRCC |
1.063750E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.482600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.405550E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.445400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.310200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.604800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.804400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.40170000004514E-06 |
| Normal-vs-N1 |
5.698500E-02 |
| Normal-vs-N2 |
8.657500E-02 |
| N0-vs-N1 |
4.162000E-01 |
| N0-vs-N2 |
2.064200E-01 |
| N1-vs-N2 |
2.111000E-01 |
|
|
